Metabolic dysfunction-associated steatotic liver disease and risk of four intrahepatic and extrahepatic diseases

Metabolic dysfunction-associated steatotic liver disease and risk of four intrahepatic and extrahepatic diseases

Introduction and Objectives: Recently, Delphi consensus proposed an overarching term steatotic liver disease (SLD), with various subcategories such as MASLD, MetALD and ALD. Our aim was to investigate the association between MASLD/MetALD/ALD and four intrahepatic and extrahepatic diseases (liver dis...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yiyuan Xiao, Sihua Xu, Wenyan Hu, Jiapeng Huang, Deke Jiang, Rong Na, Zhaoqing Yin, Jingjing Zhang, Haitao Chen
Format:	Article
Language:	English
Published:	Elsevier 2025-01-01
Series:	Annals of Hepatology
Subjects:	MASLD/MetALD/ALD NAFLD Intrahepatic and extrahepatic diseases Risk factor
Online Access:	http://www.sciencedirect.com/science/article/pii/S1665268124005337
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Diet quality and physical activity affect metabolic dysfunction-associated steatotic liver disease, metabolic dysfunction and etiology-associated steatohepatitis, and compensated advanced chronic liver disease among United States adults: NHANES 2017–2020
by: Peng Wang, et al.
Published: (2025-01-01)

Body mass index and diabetes predict severity of liver fibrosis across the spectrum of steatotic liver disease
by: Eda Kaya, et al.
Published: (2025-01-01)

Clinical characteristics of MASLD/MetALD/MAFLD/NAFLD and the relative risk analysis on metabolic disorders
by: Hong-ye Peng, et al.
Published: (2025-05-01)

Comprehensive analysis of peripheral blood free amino acids in MASLD: the impact of glycine-serine-threonine metabolism
by: Masaaki Mino, et al.
Published: (2024-12-01)

Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs): A Pan-Steatotic Liver Disease Treatment?
by: Lampros Chrysavgis, et al.
Published: (2025-06-01)

Fucoidan from Fucus vesiculosus alleviates MetALD via promoting HIF-1α ubiquitination to suppress peripheral monocyte infiltration
by: Lei Li, et al.
Published: (2025-08-01)

Impact of Gut Microbiome on Gut Permeability in Liver and Gut Diseases
by: Punnag Saha, et al.
Published: (2025-05-01)

Mitochondrial ROS, a trigger for mitochondrial dysfunction and inflammasome activation and a therapeutic target in liver diseases
by: Hala Saeed Jaara, et al.
Published: (2024-12-01)

Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017–2023
by: Donghee Kim, et al.
Published: (2025-04-01)

PHARMACOEPIDEMIOLOGICAL EVALUATION OF HEPATOTROPIC THERAPY IN REAL CLINICAL PRACTICE
by: D. V. Blinov, et al.
Published: (2015-06-01)

DIFFERENCES OF BIRTH WEIGHT AND ONSET OF ACHOLIC STOOL BETWEEN EXTRAHEPATIC AND INTRAHEPATIC CHOLESTASIS
by: Bagus Setyoboedi, et al.
Published: (2024-04-01)

Baicalin mitigates alcoholic-associated liver disease via SOCS1-driven reprogramming of macrophages
by: Sha Huang, et al.
Published: (2025-05-01)

Association of metabolic dysfunction-associated steatotic liver disease and steatosis-associated fibrosis estimator with subclinical coronary atherosclerosis: observation cohort study
by: Joonho Jeong, et al.
Published: (2025-07-01)

Enhanced Visible Light Photocatalytic Activity of Cu-Doped ZnO ALD Films Deposited on Porous Substrates
by: Piltaver Ivna Kavre, et al.
Published: (2024-01-01)

Practical Aspects of Clinical Manifestations, Pathogenesis and Therapy of Alcoholic Liver Disease and Non-alcoholic Fatty Liver Disease: Expert Opinion
by: V. V. Tsukanov, et al.
Published: (2023-11-01)

Deposition of HfO<sub>2</sub> by Remote Plasma ALD for High-Aspect-Ratio Trench Capacitors in DRAM
by: Jiwon Kim, et al.
Published: (2025-05-01)

Chitosan Oligosaccharides Prevent Alcohol-Induced Liver Disease by Attenuating Inflammation and Oxidative Stress
by: Yanglong Liu, et al.
Published: (2025-03-01)

CLINICAL AND MORPHOLOGICAL DIAGNOSTIC INTRAHEPATIC BILE DUCTS PAUCITY
by: O. E. Iryshkin, et al.
Published: (2013-05-01)

The burden of steatotic liver disease before and during the COVID-19 pandemic: Correspondence to editorial on “Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017-2023”
by: Donghee Kim, et al.
Published: (2025-04-01)

Tryptophan Metabolites in the Progression of Liver Diseases
by: Maria Reshetova, et al.
Published: (2024-11-01)

Rising drug overdose deaths in chronic liver disease in the United States, 2015–2023
by: Donghee Kim, et al.
Published: (2025-07-01)

PAUCITY OF INTRAHEPATIC BILE DUCTS
by: O. E. Iryshkin, et al.
Published: (2013-05-01)

Research progress in the role of endo cannabinoid system in liver diseases
by: BIAN Shu, et al.
Published: (2024-10-01)

Japanese experience of newborn screening for lysosomal storage diseases and adrenoleukodystrophy
by: Takanori Onuki, et al.
Published: (2025-07-01)

Assessing alpha lattice design for heat stress indices and yield stability in wheat genotypes
by: Mandeep Redhu, et al.
Published: (2025-07-01)

Progressive demyelinating childhood cerebral adrenoleukodystrophy : Assessment of communication impairment
by: Mangal Chandra Yadav, et al.
Published: (2024-01-01)

Different fungal signatures in ALD and MAFLD
by: Daya Zhang, et al.
Published: (2024-11-01)

Multidimensional sleep impairment predicts steatotic liver disease spectrum risk
by: Dongling Wang, et al.
Published: (2025-03-01)

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): the interplay of gut microbiome, insulin resistance, and diabetes
by: Ankita Dua, et al.
Published: (2025-08-01)

Association of uric acid levels with the development of metabolic dysfunction-associated and metabolic and alcohol-related/associated steatotic liver disease: a study on Japanese participants undergoing health checkups
by: Tatsuya Fukuda, et al.
Published: (2025-06-01)

Response to crizotinib in advanced intrahepatic cholangiocarcinoma with ZKSCAN1-MET fusion and MET amplification: case reports and literature review
by: Jian-Hui Wu, et al.
Published: (2025-06-01)

Efficacy of fish oil supplementation on metabolic dysfunction-associated steatotic liver disease: a meta-analysis
by: Like Zhou, et al.
Published: (2025-01-01)

Development of an innovative low-temperature PEALD process for stress-compensated TiO2 and SiO2 multilayer anti-reflective coatings
by: Duy Thanh Cu, et al.
Published: (2025-03-01)

Influence of Omega-3 and Green Tea Extract on Alcohol-Induced Liver Injury in Rats
by: Ridha Hassan Hussein, et al.
Published: (2018-07-01)

Advances in Gallium Oxide: Properties, Applications, and Future Prospects
by: Swapnodoot Ganguly, et al.
Published: (2025-05-01)

Analysis of risk factors of cholangiocarcinoma, role of diabetes mellitus and hepatitis B virus infection in the intrahepatic and extrahepatic cholangiocarcinoma: a retrospective case-based study in China
by: Hasan Md Rasadul, et al.
Published: (2025-07-01)

Gut Microbiota and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Emerging Pathogenic Mechanisms and Therapeutic Implications
by: Farah Abdelhameed, et al.
Published: (2025-03-01)

Vapor phase processing as a strategy towards MXenes formation
by: Roman G. Parkhomenko, et al.
Published: (2025-06-01)

High-Breakdown and Low-Leakage 4H-SiC MOS Capacitor Based on HfO<sub>2</sub>/SiO<sub>2</sub> Stacked Gate Dielectric in Trench Structures
by: Qimin Huang, et al.
Published: (2025-02-01)

Atomic-scale passivation strategy for stabilizing tricolor perovskite quantum dots with enhanced photoluminescence
by: Yilei Zhang, et al.
Published: (2025-04-01)